IP Library › Granted Patent US 10,336,716
Granted Patent B2
US 10,336,716 · App. 15/774,200 · Granted Jul 2, 2019

Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide

Inventors: Arnim Köhn (Klein-Winternheim, DE); Christopher Hugh Rosinger (Hofheim, DE); Christian Waldraff (Bad Vilbel, DE); Britta Olenik (Bottrop, DE); Birgit Keil (Düsseldorf, DE); Benedikt Mehl (Wuppertal, DE)
Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
C07D271/113A01N43/82C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,336,716
App. No.
15/774,200
Granted
Jul 2, 2019
Kind
B2
Abstract

A thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is described. This thermodynamically stable crystal modification has particular advantages in the stability of suspension formulations.

Claims (125)

1. A thermodynamically stable crystal modification A of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide, wherein the crystal modification

a) has an X-ray powder diffractometry pattern with the following peaks, measured at a copper anode at a K-alpha1 radiation of 1.54060 Ångstrom, specified in degrees 2 theta:

9.2

23.0

30.6

10.4

23.4

31.6

11.4

23.9

32.3

12.4

24.9

32.8

12.6

25.4

33.7

14.0

25.7

33.9

17.5

25.7

34.4

17.7

26.4

35.0

17.9

27.2

35.1

18.3

27.3

35.6

19.3

27.8

35.8

20.1

28.0

36.2

20.6

28.6

36.7

21.2

29.4

36.8

21.8

29.6

37.3

22.3

29.8

37.6

22.8

30.3

37.8

and

b) has a Raman spectrum with band maxima specified in [cm −1 ], of:

3080

1267

603

3066

1214

584

3039

1194

566

3030

1156

544

3009

1148

530

2948

1136

508

2928

1109

477

1719

1066

469

1681

1010

428

1618

965

404

1592

957

382

1577

909

359

1563

868

303

1545

803

288

1445

772

270

1412

758

231

1404

746

186

1391

720

154

1330

710

143

1303

672

105.

2. A herbicidal composition comprising a content of the thermodynamically stable crystal modification A of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide as claimed in claim 1 and one or more standard extenders and/or surface-active auxiliaries.

3. The herbicidal composition as claimed in claim 2 , wherein the 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is present to an extent of more than 90% by weight in the stable crystal modification A.

4. The herbicidal composition as claimed in claim 3 , wherein the 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is present to an extent of more than 95% by weight in the stable crystal modification A.

5. The herbicidal composition comprising the thermodynamically stable crystal modification A of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide as claimed in claim 1 and a metastable crystal modification, wherein the 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is present to an extent of more than 90% by weight in the stable crystal modification A.

6. The herbicidal composition as claimed in claim 5 , wherein the 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methyl sulfonyl)-4-(trifluoromethyl)benzamide is present to an extent of more than 95% by weight in the stable crystal modification A.

7. The herbicidal composition as claimed in claim 4 , wherein the 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is present to an extent of more than 98% by weight in the stable crystal modification A.

8. A product comprising the thermodynamically stable crystal modification A of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide as claimed in claim 1 or a composition thereof for controlling unwanted plants.

9. A method for controlling one or more unwanted plants, comprising allowing the thermodynamically stable crystal modification A as claimed in claim 1 or a composition thereof to act on the unwanted plants and/or a habitat thereof.

10. The method as claimed in claim 9 for controlling harmful plants in monocotyledonous plant crops.

11. The method as claimed in claim 9 in which the plant crops are genetically modified or have been obtained by mutation-selection.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2018
From: KÖHN, ARNIM, DR.; ROSINGER, CHRISTOPHER HUGH, DR.; WALDRAFF, CHRISTIAN, DR.; OLENIK, BRITTA, DR.; KEIL, BIRGIT; MEHL, BENEDIKT
To: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Reel/Frame 046387/0364 →
Priority Claims (1)
EP 15193615 · Nov 9, 2015 · regional
Continuity (1)
Related Publication 20180319754A1 · Nov 8, 2018